Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles

News

Sterling Expands GMP ADC Manufacturing Capacity at Deeside, UK

News

Sterling Joins the United Nations Global Compact

News

Flow Chemistry

Sterling Announces Partnership with Soligenix

News

ADCADC

Sterling Expands Bioanalytical Capabilities at Deeside, UK Site

News

High Potency APIADC

Sterling Expands HPAPI Capabilities to Further Strengthen Integrated ADC Services

News

Sterling wins Company of the Year at the Bionow annual awards